Published 09:16 IST, September 7th 2020
PIL in SC for CBI probe for using two antiviral medicines as treatment to COVID-19 patients
A plea filed in the Supreme Court has sought registration of an FIR by CBI against ten Indian pharmaceutical firms for manufacturing and selling Remdesivir and Favipiravir allegedly as medicines that treat COVID-19 patients without valid licences.
null | Image:
self
Advertisement
09:16 IST, September 7th 2020